Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity
Identifieur interne : 000700 ( PascalFrancis/Corpus ); précédent : 000699; suivant : 000701Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity
Auteurs : A. Szuba ; W. Strauss ; S. P. Sirsikar ; S. G. RocksonSource :
- Nuclear medicine communications [ 0143-3636 ] ; 2002.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Secondary lymphedema is a localized, acquired lymphatic microcirculatory disturbance that affects large numbers of patients after breast cancer therapy. There is a paucity of objective methods to quantitate lymphatic function and to anticipate the response to therapeutic interventions. We applied radionuclide lymphoscintigraphy to evaluate lymphatic transport and axillary lymph node visualization in women following breast cancer therapy to determine the utility of these data in these patients. Lymphoscintigraphy was performed after subcutaneous injection of 0.25 mCi of 99mTc-filtered sulfur colloid. Subcutaneous accumulation of radiotracer ('dermal backflow') and the visualization of axillary lymph nodes were graded using our own scoring system. The ratio of radioactivity within the affected to normal axillae (ARR) was also quantified. Nineteen patients with lymphedema after breast cancer therapy were evaluated. The disease severity was documented by serial measurements of the limb volume using the truncated cone formula. Responses to therapy were quantified after completion of the therapy. There was a correlation between the ARR and the percentage reduction in edema volume. The lymphoscintigraphic score correlated with the initial arm volume excess and with the duration of lymphedema. It can be concluded that quantitative and semi-quantitative assessment by radionuclide lymphoscintigraphy represents a potentially useful tool for the clinical assessment of upper extremity lymphedema.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 03-0180969 INIST |
---|---|
ET : | Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity |
AU : | SZUBA (A.); STRAUSS (W.); SIRSIKAR (S. P.); ROCKSON (S. G.) |
AF : | Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine/Stanford, CA/Etats-Unis (1 aut., 3 aut., 4 aut.); Division of Nuclear Medicine, Stanford University School of Medicine/ Stanford, CA/Canada (2 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Nuclear medicine communications; ISSN 0143-3636; Etats-Unis; Da. 2002; Vol. 23; No. 12; Pp. 1171-1175; Bibl. 12 ref. |
LA : | Anglais |
EA : | Secondary lymphedema is a localized, acquired lymphatic microcirculatory disturbance that affects large numbers of patients after breast cancer therapy. There is a paucity of objective methods to quantitate lymphatic function and to anticipate the response to therapeutic interventions. We applied radionuclide lymphoscintigraphy to evaluate lymphatic transport and axillary lymph node visualization in women following breast cancer therapy to determine the utility of these data in these patients. Lymphoscintigraphy was performed after subcutaneous injection of 0.25 mCi of 99mTc-filtered sulfur colloid. Subcutaneous accumulation of radiotracer ('dermal backflow') and the visualization of axillary lymph nodes were graded using our own scoring system. The ratio of radioactivity within the affected to normal axillae (ARR) was also quantified. Nineteen patients with lymphedema after breast cancer therapy were evaluated. The disease severity was documented by serial measurements of the limb volume using the truncated cone formula. Responses to therapy were quantified after completion of the therapy. There was a correlation between the ARR and the percentage reduction in edema volume. The lymphoscintigraphic score correlated with the initial arm volume excess and with the duration of lymphedema. It can be concluded that quantitative and semi-quantitative assessment by radionuclide lymphoscintigraphy represents a potentially useful tool for the clinical assessment of upper extremity lymphedema. |
CC : | 002B12B04 |
FD : | Scintigraphie; Lymphatique; Traitement manuel; Lymphoedème; Extrémité supérieure; Tumeur maligne; Glande mammaire; Mastectomie; Drainage; Postopératoire; Analyse quantitative; Surveillance; Efficacité traitement; Homme; Femelle; Prospective; Etude cas |
FG : | Exploration radioisotopique; Imagerie médicale; Appareil circulatoire pathologie; Lymphatique pathologie; Glande mammaire pathologie; Chirurgie |
ED : | Scintigraphy; Lymphatic; Manual processing; Lymphedema; Upper extremity; Malignant tumor; Mammary gland; Mastectomy; Drainage; Postoperative; Quantitative analysis; Surveillance; Treatment efficiency; Human; Female; Prospective; Case study |
EG : | Radionuclide study; Medical imagery; Cardiovascular disease; Lymphatic vessel disease; Mammary gland diseases; Surgery |
SD : | Centelleografía; Linfático; Tratamiento manual; Linfedema; Extremidad superior; Tumor maligno; Glándula mamaria; Mastectomía; Drenaje; Postoperatorio; Análisis cuantitativo; Vigilancia; Eficacia tratamiento; Hombre; Hembra; Prospectiva; Estudio caso |
LO : | INIST-21691.354000103719470030 |
ID : | 03-0180969 |
Links to Exploration step
Pascal:03-0180969Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity</title>
<author><name sortKey="Szuba, A" sort="Szuba, A" uniqKey="Szuba A" first="A." last="Szuba">A. Szuba</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Strauss, W" sort="Strauss, W" uniqKey="Strauss W" first="W." last="Strauss">W. Strauss</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Nuclear Medicine, Stanford University School of Medicine</s1>
<s2> Stanford, CA</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sirsikar, S P" sort="Sirsikar, S P" uniqKey="Sirsikar S" first="S. P." last="Sirsikar">S. P. Sirsikar</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S. G." last="Rockson">S. G. Rockson</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0180969</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0180969 INIST</idno>
<idno type="RBID">Pascal:03-0180969</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000700</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity</title>
<author><name sortKey="Szuba, A" sort="Szuba, A" uniqKey="Szuba A" first="A." last="Szuba">A. Szuba</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Strauss, W" sort="Strauss, W" uniqKey="Strauss W" first="W." last="Strauss">W. Strauss</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Nuclear Medicine, Stanford University School of Medicine</s1>
<s2> Stanford, CA</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sirsikar, S P" sort="Sirsikar, S P" uniqKey="Sirsikar S" first="S. P." last="Sirsikar">S. P. Sirsikar</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S. G." last="Rockson">S. G. Rockson</name>
<affiliation><inist:fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Nuclear medicine communications</title>
<title level="j" type="abbreviated">Nucl. med. commun.</title>
<idno type="ISSN">0143-3636</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Nuclear medicine communications</title>
<title level="j" type="abbreviated">Nucl. med. commun.</title>
<idno type="ISSN">0143-3636</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case study</term>
<term>Drainage</term>
<term>Female</term>
<term>Human</term>
<term>Lymphatic</term>
<term>Lymphedema</term>
<term>Malignant tumor</term>
<term>Mammary gland</term>
<term>Manual processing</term>
<term>Mastectomy</term>
<term>Postoperative</term>
<term>Prospective</term>
<term>Quantitative analysis</term>
<term>Scintigraphy</term>
<term>Surveillance</term>
<term>Treatment efficiency</term>
<term>Upper extremity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Scintigraphie</term>
<term>Lymphatique</term>
<term>Traitement manuel</term>
<term>Lymphoedème</term>
<term>Extrémité supérieure</term>
<term>Tumeur maligne</term>
<term>Glande mammaire</term>
<term>Mastectomie</term>
<term>Drainage</term>
<term>Postopératoire</term>
<term>Analyse quantitative</term>
<term>Surveillance</term>
<term>Efficacité traitement</term>
<term>Homme</term>
<term>Femelle</term>
<term>Prospective</term>
<term>Etude cas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Secondary lymphedema is a localized, acquired lymphatic microcirculatory disturbance that affects large numbers of patients after breast cancer therapy. There is a paucity of objective methods to quantitate lymphatic function and to anticipate the response to therapeutic interventions. We applied radionuclide lymphoscintigraphy to evaluate lymphatic transport and axillary lymph node visualization in women following breast cancer therapy to determine the utility of these data in these patients. Lymphoscintigraphy was performed after subcutaneous injection of 0.25 mCi of <sup>99m</sup>
Tc-filtered sulfur colloid. Subcutaneous accumulation of radiotracer ('dermal backflow') and the visualization of axillary lymph nodes were graded using our own scoring system. The ratio of radioactivity within the affected to normal axillae (ARR) was also quantified. Nineteen patients with lymphedema after breast cancer therapy were evaluated. The disease severity was documented by serial measurements of the limb volume using the truncated cone formula. Responses to therapy were quantified after completion of the therapy. There was a correlation between the ARR and the percentage reduction in edema volume. The lymphoscintigraphic score correlated with the initial arm volume excess and with the duration of lymphedema. It can be concluded that quantitative and semi-quantitative assessment by radionuclide lymphoscintigraphy represents a potentially useful tool for the clinical assessment of upper extremity lymphedema.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0143-3636</s0>
</fA01>
<fA03 i2="1"><s0>Nucl. med. commun.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SZUBA (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STRAUSS (W.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SIRSIKAR (S. P.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ROCKSON (S. G.)</s1>
</fA11>
<fA14 i1="01"><s1>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine</s1>
<s2>Stanford, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Nuclear Medicine, Stanford University School of Medicine</s1>
<s2> Stanford, CA</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>1171-1175</s1>
</fA20>
<fA21><s1>2002</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21691</s2>
<s5>354000103719470030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0180969</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Nuclear medicine communications</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Secondary lymphedema is a localized, acquired lymphatic microcirculatory disturbance that affects large numbers of patients after breast cancer therapy. There is a paucity of objective methods to quantitate lymphatic function and to anticipate the response to therapeutic interventions. We applied radionuclide lymphoscintigraphy to evaluate lymphatic transport and axillary lymph node visualization in women following breast cancer therapy to determine the utility of these data in these patients. Lymphoscintigraphy was performed after subcutaneous injection of 0.25 mCi of <sup>99m</sup>
Tc-filtered sulfur colloid. Subcutaneous accumulation of radiotracer ('dermal backflow') and the visualization of axillary lymph nodes were graded using our own scoring system. The ratio of radioactivity within the affected to normal axillae (ARR) was also quantified. Nineteen patients with lymphedema after breast cancer therapy were evaluated. The disease severity was documented by serial measurements of the limb volume using the truncated cone formula. Responses to therapy were quantified after completion of the therapy. There was a correlation between the ARR and the percentage reduction in edema volume. The lymphoscintigraphic score correlated with the initial arm volume excess and with the duration of lymphedema. It can be concluded that quantitative and semi-quantitative assessment by radionuclide lymphoscintigraphy represents a potentially useful tool for the clinical assessment of upper extremity lymphedema.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Scintigraphie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Scintigraphy</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Centelleografía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lymphatique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lymphatic</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Linfático</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement manuel</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Manual processing</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento manual</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Extrémité supérieure</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Upper extremity</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Extremidad superior</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Glande mammaire</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Mammary gland</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Glándula mamaria</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Mastectomie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Mastectomy</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Mastectomía</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Drainage</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Drainage</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Drenaje</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Postopératoire</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Postoperative</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Postoperatorio</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Analyse quantitative</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Quantitative analysis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Análisis cuantitativo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Surveillance</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Surveillance</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Vigilancia</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Efficacité traitement</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Treatment efficiency</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Eficacia tratamiento</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Femelle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Female</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Hembra</s0>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Prospective</s0>
<s5>23</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Prospective</s0>
<s5>23</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Prospectiva</s0>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>24</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Case study</s0>
<s5>24</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>24</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Exploration radioisotopique</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Radionuclide study</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Exploración radioisotópica</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Imagerie médicale</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Medical imagery</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Imaginería médica</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>61</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>61</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>69</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Surgery</s0>
<s5>69</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>69</s5>
</fC07>
<fN21><s1>104</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 03-0180969 INIST</NO>
<ET>Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity</ET>
<AU>SZUBA (A.); STRAUSS (W.); SIRSIKAR (S. P.); ROCKSON (S. G.)</AU>
<AF>Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine/Stanford, CA/Etats-Unis (1 aut., 3 aut., 4 aut.); Division of Nuclear Medicine, Stanford University School of Medicine/ Stanford, CA/Canada (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Nuclear medicine communications; ISSN 0143-3636; Etats-Unis; Da. 2002; Vol. 23; No. 12; Pp. 1171-1175; Bibl. 12 ref.</SO>
<LA>Anglais</LA>
<EA>Secondary lymphedema is a localized, acquired lymphatic microcirculatory disturbance that affects large numbers of patients after breast cancer therapy. There is a paucity of objective methods to quantitate lymphatic function and to anticipate the response to therapeutic interventions. We applied radionuclide lymphoscintigraphy to evaluate lymphatic transport and axillary lymph node visualization in women following breast cancer therapy to determine the utility of these data in these patients. Lymphoscintigraphy was performed after subcutaneous injection of 0.25 mCi of <sup>99m</sup>
Tc-filtered sulfur colloid. Subcutaneous accumulation of radiotracer ('dermal backflow') and the visualization of axillary lymph nodes were graded using our own scoring system. The ratio of radioactivity within the affected to normal axillae (ARR) was also quantified. Nineteen patients with lymphedema after breast cancer therapy were evaluated. The disease severity was documented by serial measurements of the limb volume using the truncated cone formula. Responses to therapy were quantified after completion of the therapy. There was a correlation between the ARR and the percentage reduction in edema volume. The lymphoscintigraphic score correlated with the initial arm volume excess and with the duration of lymphedema. It can be concluded that quantitative and semi-quantitative assessment by radionuclide lymphoscintigraphy represents a potentially useful tool for the clinical assessment of upper extremity lymphedema.</EA>
<CC>002B12B04</CC>
<FD>Scintigraphie; Lymphatique; Traitement manuel; Lymphoedème; Extrémité supérieure; Tumeur maligne; Glande mammaire; Mastectomie; Drainage; Postopératoire; Analyse quantitative; Surveillance; Efficacité traitement; Homme; Femelle; Prospective; Etude cas</FD>
<FG>Exploration radioisotopique; Imagerie médicale; Appareil circulatoire pathologie; Lymphatique pathologie; Glande mammaire pathologie; Chirurgie</FG>
<ED>Scintigraphy; Lymphatic; Manual processing; Lymphedema; Upper extremity; Malignant tumor; Mammary gland; Mastectomy; Drainage; Postoperative; Quantitative analysis; Surveillance; Treatment efficiency; Human; Female; Prospective; Case study</ED>
<EG>Radionuclide study; Medical imagery; Cardiovascular disease; Lymphatic vessel disease; Mammary gland diseases; Surgery</EG>
<SD>Centelleografía; Linfático; Tratamiento manual; Linfedema; Extremidad superior; Tumor maligno; Glándula mamaria; Mastectomía; Drenaje; Postoperatorio; Análisis cuantitativo; Vigilancia; Eficacia tratamiento; Hombre; Hembra; Prospectiva; Estudio caso</SD>
<LO>INIST-21691.354000103719470030</LO>
<ID>03-0180969</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000700 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000700 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:03-0180969 |texte= Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity }}
This area was generated with Dilib version V0.6.31. |